Physiogenex品牌介绍
品牌简介
Physiogenex 成立于 2003 年，是一家位于法国图卢兹的代谢紊乱临床前 CRO公司。15年来，我们在代谢疾病方面有着丰富的专业知识，为治疗此类疾病提供可靠的临床前研究。我们为所有代谢疾病及其并发症开发创新模型，以及广泛的测试，以证明我们客户的候选药物的有效性。Physiogenex，多年来在代谢疾病（肥胖、2 型糖尿病、NASH/MASH 纤维化、糖尿病肾病、炎症、血脂异常和心血管疾病）方面积累了强大的专业知识。作为开发预测性动物营养模型的先驱，我们的目标是帮助制药、生物技术和营养保健品公司优化临床前候选药物的研究，并降低新疗法的成本和上市时间。
Physiogenex is an expert preclinical CRO for metabolic disorders based in Toulouse, France. For more than 15 years, we have been developing and using our expertise in metabolic diseases to provide reliable preclinical studies for the treatment of such pathologies. We develop innovative models for all metabolic diseases and their complications, as well as a wide range of tests to demonstrate the effectiveness of our clients’ drug candidates.Founded in 2003, Physiogenex has built its expertise in metabolic diseases (obesity, type 2 diabetes, NASH/MASH fibrosis, diabetic nephropathy, inflammation, dyslipidemia and cardiovascular diseases) over the years with a strong and dedicated team.Pioneers in the development of predictive animal nutritional models, our aim is to help pharmaceutical, biotechnology and nutraceutical companies to optimize preclinical drug candidates’ studies and reduce the cost and time to market of new therapies.
Main product
In vitro assays
In vivo metabolic studies
Biochemical assays and histology analysis
NASH/MASH/MetALD Fibrosis
Diabetic Nephropathy
http://www.physiogenex.com/
联系我们
